Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Philips Showcases Integrated Radiation Oncology Suite to Simplify Treatment Planning

November 1, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 1, 2010 /- At this year's Annual Meeting of the American Society for Radiation Oncology (ASTRO), Royal Philips Electronics (NYSE: PHG, AEX: PHI) is demonstrating how the integration of imaging and treatment planning can help simplify the clinician and patient experience....

TOPICS:

Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Nov. 1, 2010 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that it will report results for its fiscal quarter ended September 30, 2010, on Tuesday, November 9, 2010 following the close of the U.S. financial markets.  As the Company recently...

TOPICS:

Veroâ„¢ SBRT Unleashed

November 1, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 1 /- ASTRO, the annual meeting of the American Society for Therapeutic Radiology and Oncology, marks the introduction of Vero™ SBRT to the broader North American audience. The Vero SBRT system offers the latest in radiation technology: dynamic tumor tracking and...

TOPICS:
Advertisement

AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTAâ„¢ on Monday November 1, 2010

November 1, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., Nov. 1, 2010 /- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR ) today announced a management conference call to discuss the approval of NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) by the U.S. Food and Drug Administration (FDA).  The call is...

TOPICS:

LitePoint Joins Continua Health Alliance

November 1, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Nov. 1, 2010 /- LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders. The alliance's mission is to improve the quality of personal healthcare and to establish a system...

TOPICS:

7,000 Bracelets For Hopeâ„¢ - A Rare Disease Awareness Campaign

November 1, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

DANA POINT, Calif., Nov. 1, 2010 /PRNewswire-USNewswire/ -- The Global Genes Project ( www.globalgenesproject.org ), a non-profit advocacy organization that aims to raise awareness about the prevalence of rare diseases worldwide, today launched the 7,000 Bracelets for Hope™...

TOPICS:

Humana's 3rd-quarter earnings rise 30 percent

November 1, 2010 2:45 am | by The Associated Press | News | Comments

Humana Inc.'s third-quarter net income climbed 30 percent partly on higher than expected medicals claims as Medicare Advantage enrollment rose.The health insurer also boosted its full-year earnings guidance on Monday.Humana is the second largest provider of Medicare Advantage plans, trailing...

Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD

November 1, 2010 1:34 am | by Bio-Medicine.Org | News | Comments

Medivir Notes That Partner Tibotec Announced Week 24 Interim Results Fro...

TOPICS:
Advertisement

Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for Pixuvri®

November 1, 2010 1:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Nov. 1, 2010 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that it has submitted a Marketing Authorization Application ("MAA") to the European Medicines Agency ("EMA") for Pixuvri® (pixantrone dimaleate) as monotherapy for the treatment of adult...

TOPICS:

Walsin Lihwa signs investment cooperation agreement with German solar energy company Solarion AG

November 1, 2010 12:37 am | by I-Micronews | News | Comments

Walsin Lihwa signed an investment cooperation agreement with Solarion AG, a Germany-based solar energy company in Leipzig.

Memjet launches high-speed, color on-demand printing technology for the labels and packaging markets

November 1, 2010 12:36 am | by I-Micronews | News | Comments

Memjet, the global leader in color printing technologies that provide remarkable speeds and affordability, will launch its color on-demand printing technology for the labels and packaging markets at PACK EXPO International 2010 (October 31-November 3, booth 3866).

November/December 2010 Digital Edition

November 1, 2010 12:00 am | Digital Editions | Comments

Inside: Read about different outsourcing generations in “4G Outsourcing Partnerships,” from Minnetronix. Shared are professionals’ opinions on the year in review, machining, and patient management devices. Additionally, read about innovative technologies for motors, compressor airs out pump shortcomings, pressure sensors, and medical imaging. Check out the selection of products, as well as the offerings for engineers in Design notes.

TOPICS:

Racial and ethnic disparities impact care for children with frequent ear infections

October 31, 2010 8:38 pm | by EurekAlert | News | Comments

(American Academy of Otolaryngology -- Head and Neck Surgery) Racial and ethnic disparities among children with frequent ear infections significantly influence access to affordable health care, according to new research published in the November 2010 issue of Otolaryngology -- Head...

TOPICS:

Immune system assassin's tricks visualised for the first time

October 31, 2010 11:35 am | by EurekAlert | News | Comments

(Biotechnology and Biological Sciences Research Council) Scientists from the UK and Australia have seen the human immune system's assassin -- a protein called perforin -- in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council...

TOPICS:

How do we kill rogue cells?

October 31, 2010 11:35 am | by EurekAlert | News | Comments

(Science in Public) A team of Melbourne and London researchers have shown how a protein called perforin punches holes in, and kills, rogue cells in our bodies. Their discovery of the mechanism of this assassin is published today in the science journal Nature.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading